Intelence and Urticaria aggravated - a phase IV clinical study of FDA data

Summary:

Urticaria aggravated is reported as a side effect among people who take Intelence (etravirine), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Norvir, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Urticaria aggravated when taking Intelence. It is created by eHealthMe based on reports of 3,739 people who have side effects when taking Intelence from the FDA, and is updated regularly.

What is Intelence?

Intelence has active ingredients of etravirine. It is often used in hiv infection. eHealthMe is studying from 3,797 Intelence users. Check the latest studies of Intelence.

What is Urticaria aggravated?

Urticaria aggravated (rash of round, red welts on the skin that itch intensely) is found to be associated with 2,058 drugs and 723 conditions by eHealthMe. Check the latest studies of Urticaria aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

3,739 people reported to have side effects when taking Intelence.
Among them, 33 people (0.88%) have Urticaria aggravated.

Could Intelence cause Urticaria aggravated?

Among these 33 people:

How long have people been on Intelence when they have Urticaria aggravated? *

What is the gender of people who have Urticaria aggravated when taking Intelence? *

female: 46.88 %
male: 53.12 %

What is the age of people who have Urticaria aggravated when taking Intelence? *

What are other drugs people take besides Intelence? *

What are other side effects people have besides Urticaria aggravated? *

Rashes (redness): 8 people, 24.24%
Itching: 6 people, 18.18%
Nausea (feeling of having an urge to vomit): 6 people, 18.18%
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 5 people, 15.15%
Wound: 4 people, 12.12%
Dizziness: 4 people, 12.12%
Headache (pain in head): 4 people, 12.12%
White Blood Cell Count Decreased: 4 people, 12.12%
Muscle Spasms (muscle contraction): 4 people, 12.12%
Nasopharyngitis (inflammation of the nasopharynx): 4 people, 12.12%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 12.12%
Stress And Anxiety: 1 person, 3.03%
Lipohypertrophy (a lump under the skin caused by accumulation of extra fat at the site of many subcutaneous injections of insulin): 1 person, 3.03%
High Blood Cholesterol: 1 person, 3.03%
Friedreich's Ataxia (damage to the nervous system): 1 person, 3.03%
Dyslipidaemia (abnormal amount of lipids): 1 person, 3.03%
Diabetes: 1 person, 3.03%
Cardiac Disorder: 1 person, 3.03%
Bipolar Disorder (mood disorder): 1 person, 3.03%
Back Pain: 1 person, 3.03%

* Approximation only. Some reports may have incomplete information.

Do you take Intelence and have Urticaria aggravated?

- Check whether Urticaria aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Intelence:

Intelence (3,797 reports)

Browse all side effects of Intelence:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urticaria aggravated:

Urticaria aggravated (2,058 drugs)

Browse all the conditions that are associated with Urticaria aggravated:

Urticaria aggravated (723 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on etravirine (the active ingredients of Intelence) and Intelence (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.